Chindhalore Chaitali Ashish, Dakhale Ganesh N, Gajbhiye Snehalata V, Gupta Ashish Vijay, Khapeka Shivam V
Department of Pharmacology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.
Perspect Clin Res. 2024 Oct-Dec;15(4):188-194. doi: 10.4103/picr.picr_257_23. Epub 2024 Apr 8.
Ethical conduct of research depends on the voluntary expression of consent and adequate disclosure of information about the research in informed consent documents (ICDs).
The objective of this study was to analyze ICDs of academic studies for compliance with National Ethical Guidelines for Biomedical and Health Research laid down by the Indian Council of Medical Research (ICMR) and to determine the readability of ICDs using the Flesch-Kincaid Grade Level scale and Flesch reading-ease (FRE) score.
ICDs of academic research projects submitted during 2020-22 were retrieved from the IEC office and analyzed for compliance with ICMR 2017 guidelines. The readability of the documents was assessed by the Flesch-Kincaid Grade Level Scale and FRE score.
Among 177 protocols analyzed, the most common were epidemiological studies (36.72%), followed by diagnostic studies (28.81%). Vernacular translations of ICDs were present in significantly more studies in 2022 ( = 7.18, = 0.02) as compared to 2020 and 2021. FREs score was 45.75 ± 10.76, and Flesch-Kincaid Grade Level was 8.67 ± 1.44. Content analysis of participant information sheet (PIS) revealed that significantly more PIS submitted in 2022 mentioned expected duration of participation ( = 6.95, < 0.001), benefit to patient/community ( = 26.63, < 0.001), disclosure of foreseeable risk or discomfort ( = 21.72, < 0.001), payment for participation ( = 21.72, < 0.001), and identity of research team and contact details ( = 18.58, < 0.001). Compliance score was significantly better in 2022 as compared to 2020 and 2021.
Gradually, ICDs became more compliant with ICMR guidelines. Still, there is scope for improvement in ICDs regarding content and readability so that patients can comprehend facts easily to make informed decisions in a real sense.
研究的道德行为取决于同意的自愿表达以及在知情同意文件(ICD)中充分披露有关研究的信息。
本研究的目的是分析学术研究的ICD是否符合印度医学研究理事会(ICMR)制定的国家生物医学和健康研究伦理指南,并使用弗莱什-金凯德年级水平量表和弗莱什阅读简易度(FRE)分数来确定ICD的可读性。
从IEC办公室检索2020 - 2022年期间提交的学术研究项目的ICD,并分析其是否符合ICMR 2017指南。通过弗莱什-金凯德年级水平量表和FRE分数评估文件的可读性。
在分析的177份方案中,最常见的是流行病学研究(36.72%),其次是诊断研究(28.81%)。与2020年和2021年相比,2022年有显著更多的研究提供了ICD的方言翻译(χ² = 7.18,P = 0.02)。FRE分数为45.75 ± 10.76,弗莱什-金凯德年级水平为8.67 ± 1.44。参与者信息表(PIS)的内容分析显示,2022年提交的PIS中显著更多地提到了预期参与时长(χ² = 6.95,P < 0.001)、对患者/社区的益处(χ² = 26.63,P < 0.001)、可预见风险或不适的披露(χ² = 21.72,P < 0.001)、参与的报酬(χ² = 21.72,P < 0.001)以及研究团队的身份和联系方式(χ² = 18.58,P < 0.001)。与2020年和2021年相比,2022年的合规分数显著更高。
ICD逐渐更加符合ICMR指南。然而,ICD在内容和可读性方面仍有改进空间,以便患者能够真正轻松理解事实并做出明智的决定。